IPP Bureau
Capnopharm to acquire operational assets of Capnomed
By IPP Bureau - July 10, 2022
Capnomed successfully introduced the medical device Capnopen, the gold standard of laparoscopic nebulizers.
WuXi XDC and AbTis sign MoU for manufacturing of antibody drug conjugates
By IPP Bureau - July 10, 2022
AbTis will have access to WuXi XDC's integrated services for linker and payload manufacturing
ALPLA acquires Polish packaging manufacturer APON
By IPP Bureau - July 08, 2022
The acquisition continues the growth and expansion course of the ALPLApharma business division established in 2019
Evonik launches non-animal-derived collagen platform for medical device applications
By IPP Bureau - July 08, 2022
Fermentation-based manufacturing leverages Evonik’s biotechnology platform
Dr. Reddy's Laboratories updates on PAI of formulations facility
By IPP Bureau - July 08, 2022
The company has been issued a Form 483 with two observations which the company will address within the stipulated timeline.
US FDA Inspection at Alkem's Indore manufacturing facility
By IPP Bureau - July 08, 2022
This GMP and Pre-Approval Inspection is part of the routine business operations and the company shall submit to US FDA within the stipulated timeline
Lupin’s Somerset manufacturing plant Receives EIR from US FDA
By IPP Bureau - July 08, 2022
The US FDA has determined that the inspection classification of the facility is Voluntary Action Indicated
Glenmark launches Sitagliptin and its FDC at affordable price
By IPP Bureau - July 08, 2022
These medicines have low risk of hypoglycemia, provide beta cell protection, offer cardio-renal benefits and are safe for patients with kidney or liver conditions and senior citizens
WuXi STA opens Oligonucleotide and Peptide manufacturing facility
By IPP Bureau - July 08, 2022
Site Enhances New Modality CRDMO Platform Capacity for Customers
IIT Delhi-backed startup develops antimicrobial solution for textiles
By IPP Bureau - July 07, 2022
Medicfibers in collaboration with AIIMS New Delhi, has developed an antimicrobial solution Viroclog that when applied as a coating on textiles, provides long-lasting protection against HAI by reducing virus, bacteria, fungi survival on fabric
Lonza to build large-scale fill & finish facility in Switzerland
By IPP Bureau - July 07, 2022
The new facility will be delivered through an investment of approximately CHF 500 million and is expected to be completed in 2026
Eugia Pharma receives USFDA approval for Triamcinolone Acetonide Injectable Suspension
By IPP Bureau - July 07, 2022
This is the 142nd ANDA (including 8 tentative approvals received) out of Eugia Pharma Specialty Group (EPSG) facilities, manufacturing both oral and sterile specialty products.
NHA announces successful onboarding of 1 lakh+ healthcare facilities
By IPP Bureau - July 07, 2022
It includes both public and private health facilities including hospitals, clinics, diagnostic laboratories, and imaging centers
Wacker to expand mRNA-based actives capacity at Halle, Germany
By IPP Bureau - July 06, 2022
Company is investing more than €100 million in the expansion of the Halle site
Merck launches international platform to discuss ‘Next-Gen Labs’
By IPP Bureau - July 06, 2022
Merck is organizing one of the biggest South APAC Virtual Conclave on ‘Next-Gen Labs’ on 20th July.
